Important: All continuing pharmacy education (CPE) credit(s) must be claimed within 60 days of enrolling in an online activity.   Learn More Learning activities are available for a specific time after the activity has been accessed or opened. Be sure to know the close date of your activities. Each activity shows a "Close Date" in the far right side next to the activity title. All activities must be completed before the close date or they will expire and you will not be able to claim CPE credit.  Click here for instructions on how to get started.                                                                                                                                                                                               

Main Catalog

Found 113
Sort by
Home Study Programs
Member Free
Non-Member Free

Duchenne Muscular Dystrophy and Formulary Decision-Making Strategies Home Study

Contact Hours: 1.0. Duchenne muscular dystrophy (DMD) is an x-linked genetic disease caused by mutations in the DMD gene that result in the lack of production of the dystrophin protein.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

Utilizing Patient Reported Outcomes to Impact Major Depressive Disorder Management Home Study

Contact Hours: 1.0. Major depressive disorder (MDD) is estimated to affect more than 16 million adults in the United States, impacting 6.7% of the population.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

The Immuno-Oncology Pipeline and the Managed Care Considerations Home Study

Contact Hours: 1.0 Cancer has been described in medicine for centuries, so why is there not a cure for it yet? The answer is uncertain, but new research into immunotherapy is showing progress in increasing remission rates of cancer patients.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

Spinal Muscular Atrophy: Patient Outcomes and Cost Considerations Home Study

Contact Hours: 1.0. Spinal muscular atrophy (SMA) is a rare, genetic, neuromuscular disease that causes progressive muscle weakness and deterioration. SMA is categorized into four types, depending on the severity of the disease, and each type presents its own unique clinical management challenges.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

Managing Multiple Sclerosis to Improve Patient and Payer Outcomes Home Study

Contact Hours: 1.0. Multiple sclerosis (MS) affects approximately 400,000 individuals in the United States and 2.5 million people worldwide.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

Improving Outcomes for Hereditary Angioedema

Contact Hours: 1.0 - Hereditary angioedema (HAE) affects approximately 1 in 50,000 people and can cause severe, potentially life-threatening swelling.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

Biosimilars Basics and Beyond: The Science of Biosimilars Home Study

Contact Hours: 1.0 Biosimilars have the potential to produce significant health care cost savings in the United States and improve patient access to treatment options.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

Biosimilars Basics and Beyond: Regulating Biosimilars Home Study

Contact Hours: 1.0 Biosimilars have the potential to produce significant health care cost savings in the United States and improve patient access to treatment options.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

A Managed Care Evaluation of the Dyslipidemia Management Advances

Contact Hours: 1.0 Over 73 million adults in the United States have dyslipidemia and are at elevated risk for atherosclerotic cardiovascular disease.
Free Home Study
Home Study Programs
Member Free
Non-Member Free

The Promise and the Challenge of Personalized Medicine for Managed Care Home Study

Contact Hours: 1.5. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live symposium activity presented at AMCP Nexus 2016.
Free Symposia